ARENA PHARMACEUTICALS INC's ticker is ARNA and the CUSIP is 040047607. A total of 231 filers reported holding ARENA PHARMACEUTICALS INC in Q3 2019. The put-call ratio across all filers is 1.72 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2021 | $60,025,000 | +56.0% | 645,848 | -0.0% | 4.30% | +69.6% |
| Q3 2021 | $38,479,000 | -8.6% | 646,162 | +4.7% | 2.54% | +0.4% |
| Q2 2021 | $42,088,000 | +75.2% | 617,124 | +78.2% | 2.52% | +58.5% |
| Q1 2021 | $24,028,000 | -2.9% | 346,274 | +7.5% | 1.59% | -13.0% |
| Q4 2020 | $24,737,000 | +24.7% | 321,967 | +21.3% | 1.83% | -10.0% |
| Q3 2020 | $19,845,000 | +18.9% | 265,339 | +0.1% | 2.03% | +4.6% |
| Q2 2020 | $16,687,000 | +325.7% | 265,090 | +184.0% | 1.94% | +190.6% |
| Q1 2020 | $3,920,000 | -53.5% | 93,329 | -49.7% | 0.67% | -37.9% |
| Q4 2019 | $8,436,000 | -3.4% | 185,728 | -2.7% | 1.08% | -18.3% |
| Q3 2019 | $8,735,000 | +233.3% | 190,838 | +326.9% | 1.32% | +262.6% |
| Q2 2019 | $2,621,000 | – | 44,704 | – | 0.36% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Prosight Management, LP | 252,500 | $11,320,000 | 4.95% |
| Rubric Capital Management LP | 857,103 | $38,424,000 | 3.59% |
| PFM Health Sciences, LP | 3,255,230 | $145,932,000 | 3.22% |
| Partner Investment Management, L.P. | 40,605 | $1,820,000 | 2.10% |
| DAFNA Capital Management LLC | 93,942 | $4,211,000 | 1.82% |
| Atika Capital Management LLC | 195,000 | $8,742,000 | 1.78% |
| Perceptive Advisors | 1,400,171 | $62,770,000 | 1.77% |
| EMORY UNIVERSITY | 47,779 | $2,142,000 | 1.51% |
| Rhenman & Partners Asset Management AB | 234,558 | $10,515,000 | 1.23% |
| Eversept Partners, LP | 75,721 | $3,394,572 | 0.99% |